Get Started

PEPG

NASD PepGen Inc.
Oct 27, 2026 · 8:08 AM ET LAST TRADE Market Closed

$2.49 ↑ +0.00 (+0.00%) Trading Up from the previous close of $2.49

YTD change
-61.75%
vs 20-day SMA
+0.08%
vs 200-day SMA
-19.66%

Price ranges

Previous day
$2.46 $2.68
open $2.51 close $2.49
-$0.02 (-0.80%)
Today
$0.00 $0.00
$2.49
Past week
$2.44 $2.99
from $2.70 now $2.49
-$0.21 (-7.78%)
Past month
$2.21 $2.99
from $2.59 now $2.49
-$0.10 (-3.86%)
This year
$1.31 $7.80
from $6.51 now $2.49
-$4.02 (-61.75%)

Price & Performance

+0.89 (+55.62%) / 6M

$1.18$1.99$2.79$3.59Apr 27Jul 28Oct 26

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 87.5% away from all-time highs of $20.00
  • PEPG is down 62% since the beginning of the year
  • PEPG is down 54% over the past 12 months
  • PEPG is down 4% over the past 1 month
  • 8% of all PEPG investors are betting against PEPG

PEPG reads not so good: price sits above one of the two key moving averages, the 12-month move is -54.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.26
Earnings momentum +3.9% Quarterly EPS growth
Quarterly change +3.9%

Valuation

P/E ratio N/A
Enterprise value $71.2M
Beta 2.71

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$117.2M
Debt$16.1K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $172.5M

PepGen Inc. develops oligonucleotide therapies. It is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. The company was founded on November 9, 2020 and is headquartered in Boston, MA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $444.63 +1.22%
MRNA Moderna, Inc. $198.85 -0.62%
RVMD Revolution Medicines, Inc. $183.90 -1.65%
ROIV Roivant Sciences Ltd. $36.05 -1.21%
BNTX BioNTech SE Sponsored ADR $86.86 -1.42%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.